OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 129 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,469,000 | -65.5% | 2,609,974 | +5.4% | 0.00% | -60.0% |
| Q4 2015 | $4,258,000 | -47.0% | 2,475,245 | -34.9% | 0.01% | -50.0% |
| Q3 2015 | $8,029,000 | -59.6% | 3,805,053 | -5.3% | 0.01% | -47.4% |
| Q2 2015 | $19,898,000 | +133.1% | 4,019,639 | +268.6% | 0.02% | +111.1% |
| Q1 2015 | $8,538,000 | +82.2% | 1,090,512 | +41.0% | 0.01% | +125.0% |
| Q4 2014 | $4,685,000 | -29.1% | 773,295 | -50.1% | 0.00% | -20.0% |
| Q3 2014 | $6,606,000 | +42.8% | 1,550,572 | +107.1% | 0.01% | +25.0% |
| Q2 2014 | $4,627,000 | +28.9% | 748,771 | +35.6% | 0.00% | 0.0% |
| Q1 2014 | $3,589,000 | +16.4% | 552,100 | +0.9% | 0.00% | +33.3% |
| Q4 2013 | $3,083,000 | +338.5% | 547,413 | +377.7% | 0.00% | +200.0% |
| Q3 2013 | $703,000 | +66.6% | 114,591 | +59.1% | 0.00% | – |
| Q2 2013 | $422,000 | +2.9% | 72,022 | +10.0% | 0.00% | – |
| Q1 2013 | $410,000 | – | 65,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |